First Horizon Advisors, Inc. Beam Therapeutics Inc. Transaction History
First Horizon Advisors, Inc.
- $3.58 Billion
- Q3 2024
A detailed history of First Horizon Advisors, Inc. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 985 shares of BEAM stock, worth $26,398. This represents 0.0% of its overall portfolio holdings.
Number of Shares
985
Previous 1,002
1.7%
Holding current value
$26,398
Previous $23,000
4.35%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BEAM
# of Institutions
235Shares Held
75.1MCall Options Held
438KPut Options Held
232K-
Farallon Capital Management LLC San Francisco, CA8.21MShares$220 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.84MShares$210 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$205 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.53MShares$175 Million1.52% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.83MShares$130 Million71.21% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.89B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...